Join an expert panel for an overview of the legal and regulatory framework for prescribing nicotine vaping products in Australia after 1 October. The evidence on nicotine vaping products and their place in treatment for smoking cessation care will be summarised, as will key clinical practice considerations for prescribing nicotine vaping products.
Webinar: Smoking cessation – practice considerations after 1 October
Upcoming legal and regulatory changes to nicotine and considerations for prescribers
Date and time: Wednesday, September 8, 6:30pm (AEST)
Facilitator/Chair: Dr Sarah White
Presenters: Prof John Skerritt and Prof Nick Zwar
Duration: 1 hour
Legal and regulatory framework for NVPs in Australia (Prof John Skerritt):
- TGA rescheduling decision for nicotine- overview and rationale.
- Prescribing pathways for nicotine vaping products.
Nicotine vaping products (Prof Nick Zwar):
- Overview of efficacy and safety evidence for nicotine vaping products.
- Role of NVPs in smoking cessation.
- Considerations for prescribers.
Question and answer session will follow.
Please note: This event is open only to health professionals registered to practice in Australia. Employees and representatives of companies that manufacture, distribute or sell nicotine vaping or tobacco products are not permitted to register. Representatives of companies which provide strategic, PR, legal or any other professional services to any company that manufactures, distributes or sells nicotine vaping or tobacco products are also not permitted to register.